Naples Univ opens new H-T screening lab

17 June 2007

Symyx Technologies, a US firm helping companies maximize the effectiveness and success of their R&D programs, says that the Federico II University in Naples, Italy, is opening a new academic research facility based on its Parallel Pressure Reactor workflow. Global industry and academic polyolefins research experts, including Symyx scientists, will be on hand for the official inauguration of the facility on June 22, and will present on high-throughput technologies and applications at the University's international symposium, the US company adds.

"The Symyx PPR has enabled breakthrough research and significant commercial innovations in polyolefins, a field that previously was deemed to be mature," said Vincenzo Busico, a professor at the Federico II University. "With the PPR at the center of our new research facility, we continue our tradition of spurring innovation and use of advanced technologies in catalysis and polymer programs throughout our university and partner networks," he added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight